Back to Search
KELLEY NEWTON, MD
Internal Medicine Physician
NPI: 1508305723IndividualAccepts Medicare
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
PG193803(OR)
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
MD212741(OR)
Education
OREGON HEALTH SCIENCES UNIVERSITY SCHOOL OF MEDICINE
Class of 2019
Research & Publications (20)
Pedometers and text messaging to increase physical activity: randomized controlled trial of adolescents with type 1 diabetes.
PMID 19228863·Diabetes Care·2009
4-observational
Current and future sustainability of island coral reef fisheries.
PMID 17382547·Curr Biol·2007
7-preclinical
Soy protein and bone mineral density in older men and women: a randomized trial.
PMID 16730418·Maturitas·2006
4-observational
Treatment of vasomotor symptoms of menopause with black cohosh, multibotanicals, soy, hormone therapy, or placebo: a randomized trial.
PMID 17179056·Ann Intern Med·2006
2-rct
The Herbal Alternatives for Menopause (HALT) Study: background and study design.
PMID 16186076·Maturitas·2005
2-rct
The impact of comorbidities on hormone use. After the 2000 release of the Women's Health Initiative.
PMID 15857493·J Gen Intern Med·2005
4-observational
Kinase RIP3 is dispensable for normal NF-kappa Bs, signaling by the B-cell and T-cell receptors, tumor necrosis factor receptor 1, and Toll-like receptors 2 and 4.
PMID 14749364·Mol Cell Biol·2004
7-preclinical
Myodegeneration in EDA-A2 transgenic mice is prevented by XEDAR deficiency.
PMID 14749376·Mol Cell Biol·2004
7-preclinical
Phenoloxidase and QX disease resistance in Sydney rock oysters (Saccostrea glomerata).
PMID 15177110·Dev Comp Immunol·2004
7-preclinical
Estrogen therapy and risk of cardiovascular events among women with type 2 diabetes.
PMID 14514584·Diabetes Care·2003
8-other
Use of alternative therapies for menopause symptoms: results of a population-based survey.
PMID 12100799·Obstet Gynecol·2002
4-observational
Effects of a dominant interfering mutant of FADD on signal transduction in activated T cells.
PMID 11250157·Curr Biol·2001
7-preclinical
What factors account for hormone replacement therapy prescribing frequency?
PMID 11451615·Maturitas·2001
8-other
Ionizing radiation and chemotherapeutic drugs induce apoptosis in lymphocytes in the absence of Fas or FADD/MORT1 signaling. Implications for cancer therapy.
PMID 10620618·J Exp Med·2000
7-preclinical
FADD/MORT1 regulates the pre-TCR checkpoint and can function as a tumour suppressor.
PMID 10698935·EMBO J·2000
7-preclinical
Endometrial hyperplasia risk in relation to recent use of oral contraceptives and hormone therapy.
PMID 19064186·Ann Epidemiol·2009
8-other
Daidzein-metabolizing phenotypes in relation to mammographic breast density among premenopausal women in the United States.
PMID 18821061·Breast Cancer Res Treat·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 10150 SE 32ND AVE
MILWAUKIE, OR 97222 - Phone
- (503) 513-8641
Quick Facts
- NPI
- 1508305723
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile